Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
12.17
+0.16 (1.33%)
Nov 20, 2024, 4:00 PM EST - Market closed
Dynavax Technologies Employees
Dynavax Technologies had 408 employees as of December 31, 2023. The number of employees increased by 57 or 16.24% compared to the previous year.
Employees
408
Change (1Y)
57
Growth (1Y)
16.24%
Revenue / Employee
$639,240
Profits / Employee
$50,191
Market Cap
1.60B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teladoc Health | 5,600 |
Certara | 1,391 |
InMode | 581 |
BioCryst Pharmaceuticals | 536 |
Immunocore Holdings | 497 |
Travere Therapeutics | 380 |
Kiniksa Pharmaceuticals International, | 297 |
Nurix Therapeutics | 284 |
DVAX News
- 7 days ago - Dynavax Technologies: What The Stock Buyback Means. What It Doesn't - Seeking Alpha
- 9 days ago - Dynavax Announces $100 Million Accelerated Share Repurchase Program - PRNewsWire
- 13 days ago - Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates - PRNewsWire
- 13 days ago - Dynavax Announces $200 Million Share Repurchase Program - PRNewsWire
- 14 days ago - Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX) - Business Wire
- 23 days ago - Dynavax Adopts Limited-Duration Stockholder Rights Plan - PRNewsWire
- 27 days ago - Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024 - PRNewsWire